New book by Larry Connors Click here Improve your trading - See how
The contract makes AMS' Monarc(R) Subfascial Hammock, MiniArc(R) Single-Incision Sling, and SPARC(R) Sling System available to women treated in any NHS hospital in the region through NHS (the public healthcare provider) serviced and supported by the Normanton centre.
"We are pleased to have our clinically proven products, Monarc, MiniArc and Sparc, included in this tender. Our Monarc device is one of the leading transobturator slings on the market, bringing relief to women around the world who suffer from SUI," said Anthony Bihl, president and chief executive officer at American Medical Systems.
The Monarc Subfascial Hammock Sling System has been featured in more than 200 clinical studies by numerous experts in the field of urology and gynecology. One recent randomized prospective study found the Monarc delivered comparable performance to the leading retropubic sling, but with fewer bladder perforations (Green Journal, March 2008, Barber et al.).
AMS' portfolio of female SUI treatment solutions restore urinary continence through minimally invasive procedures and are suitable for a wide range of patients. Worldwide, more than 600,000 women have been implanted with the Monarc, MiniArc and SPARC systems.
For more information about the AMS' complete line of treatment solutions, visit www.americanmedicalsystems.com.
About American Medical Systems:
American Medical Systems Holdings, Inc., headquartered in Minnetonka, Minn., is a diversified supplier of world-class medical devices and procedures used to treat male and female urinary incontinence, erectile dysfunction, prostate disorders (including Benign Prostatic Hyperplasia), urethral strictures, excessive menstrual bleeding (known as menorrhagia), pelvic organ prolapse and fecal incontinence. These conditions significantly diminish one's quality of life and can profoundly affect social relationships. AMS' products allow physicians to restore both dignity and control to their patients, through the delivery of therapies or the surgical implantation of medical devices. AMS has a long-standing reputation for product performance and innovation and partners with urologists, gynecologists, urogynecologists and colorectal surgeons to support their needs and develop new techniques. In recent years, the number of people seeking treatment has increased as a result of longer lives, higher-quality-of-life expectations and greater awareness of new treatment alternatives. AMS' products reduce or eliminate the incapacitating effects of these diseases, often through minimally invasive therapies. The Company's products were used to treat approximately 320,000 patients in 2008.
More information about the Company and its products can be found at its website www.AmericanMedicalSystems.com and in the Company's Annual Report on Form 10-K for 2008 and its other SEC filings.
SOURCE: American Medical Systems Holdings, Inc.
Media Contact: Lisa Kornblatt SS|PR 847-415-9330 lkornblatt@sspr.com
More News:
Market Updates |
Stock Alerts |
All Trading News |
Stock Index
About TradingMarkets | Contact | Advertise | Careers | Link to Us | Site Map | Help | Terms & Conditions | Privacy Policy | Return Policy | Testimonials | Feedback
The Connors Group, Inc. ("Company") is not an investment advisory service, nor a registered investment advisor or broker-dealer and does not purport to tell or suggest which securities or currencies customers should buy or sell for themselves. The analysts and employees or affiliates of Company may hold positions in the stocks, currencies or industries discussed here. You understand and acknowledge that there is a very high degree of risk involved in trading securities and/or currencies. The Company, the authors, the publisher, and all affiliates of Company assume no responsibility or liability for your trading and investment results. Factual statements on the Company's website, or in its publications, are made as of the date stated and are subject to change without notice.
It should not be assumed that the methods, techniques, or indicators presented in these products will be profitable or that they will not result in losses. Past results of any individual trader or trading system published by Company are not indicative of future returns by that trader or system, and are not indicative of future returns which be realized by you. In addition, the indicators, strategies, columns, articles and all other features of Company's products (collectively, the "Information") are provided for informational and educational purposes only and should not be construed as investment advice. Examples presented on Company's website are for educational purposes only. Such set-ups are not solicitations of any order to buy or sell. Accordingly, you should not rely solely on the Information in making any investment. Rather, you should use the Information only as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments. You should always check with your licensed financial advisor and tax advisor to determine the suitability of any investment.
HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN INHERENT LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING AND MAY NOT BE IMPACTED BY BROKERAGE AND OTHER SLIPPAGE FEES. ALSO, SINCE THE TRADES HAVE NOT ACTUALLY BEEN EXECUTED, THE RESULTS MAY HAVE UNDER- OR OVER-COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFITS OR LOSSES SIMILAR TO THOSE SHOWN.
The Connors Group, Inc.
10 Exchange Place, Suite 1800
Jersey City, NJ 07302
© Copyright 2009 The Connors Group, Inc.
